(Q49051437)

18 February 2018

title

Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay. (English)

1 reference

18 February 2018

1 reference

1

1 reference

18 February 2018

Jo Vandesompele

12

1 reference

18 February 2018

Frank Speleman

2

object named as

Frank Speleman

1 reference

18 February 2018

John Lunec

4

object named as

John Lunec

1 reference

18 February 2018

author name string

Valérie Combaret

3

1 reference

18 February 2018

Geneviève Laureys

5

1 reference

18 February 2018

Bert H J Eussen

6

1 reference

18 February 2018

Nadine Francotte

7

1 reference

18 February 2018

Julian Board

8

1 reference

18 February 2018

Andy D J Pearson

9

1 reference

18 February 2018

Anne De Paepe

10

1 reference

18 February 2018

Nadine Van Roy

11

1 reference

18 February 2018

publication date

1 February 2002

1 reference

18 February 2018

published in

Modern Pathology

1 reference

18 February 2018

volume

15

1 reference

18 February 2018

page(s)

159-166

1 reference

18 February 2018

issue

2

1 reference

18 February 2018

https://scigraph.springernature.com/pub.10.1038/modpathol.3880508

exact match

0 references

cites work

Molecular biology of neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880508

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880508

Detection of MYCN amplification in neuroblastoma using competitive PCR quantitation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880508

MYCN amplification by differential PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880508

Real time quantitative PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880508

Overexpression of a DEAD box protein (DDX1) in neuroblastoma and retinoblastoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880508

Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880508

Co-amplification of a novel gene, NAG, with the N-myc gene in neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880508

1;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880508

Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880508

Product differentiation by analysis of DNA melting curves during the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880508

Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880508

Advances in quantitative PCR technology: 5' nuclease assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880508

N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880508

7 January 2021

Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880508

7 January 2021

Fluorescence in situ hybridization combined with immunohistochemistry for highly sensitive detection of chromosome 1 aberrations in neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880508

7 January 2021

Analysis of candidate gene co-amplification with MYCN in neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880508

7 January 2021

Clinical value of N-myc oncogene amplification in 52 patients with neuroblastoma included in recent therapeutic protocols

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880508

7 January 2021

Novel approach to quantitative polymerase chain reaction using real-time detection: application to the detection of gene amplification in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880508

7 January 2021

Quick quantitative analysis of gene dosages associated with prognosis in neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880508

7 January 2021

10.1038/MODPATHOL.3880508

Identifiers

DOI

1 reference

18 February 2018

Dimensions Publication ID

0 references

1 reference

18 February 2018